Avidity Biosciences: Strong Buy With Promising RNA Therapeutics Pipeline
Avidity Biosciences(RNA) seekingalpha.com·2024-05-19 15:23BlackJack3D/iStock via Getty Images Avidity Biosciences, Inc. (NASDAQ:RNA) specializes in targeted RNA therapeutics using its Antibody Oligonucleotide Conjugates (AOC) platform. RNA can create therapies for previously unreachable tissues and cells with this approach. RNA's platform provides monoclonal antibodies (mAbs) that accurately supply oligonucleotide treatments to interfere with or modify pathological gene expression and address the root causes of genetic diseases. RNA's pipeline includes programs in ...